Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sygnature Discovery
Biotech
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders
Less than a year in, BenevolentAI CEO is out. Deshaies descends from Amgen research perch. Sage’s reorg scrambles executive team.
Darren Incorvaia
,
Zoey Becker
Oct 18, 2024 8:30am
Sygnature Discovery pumps £3.75M into data management system
Nov 8, 2023 3:10pm
Sygnature Discovery acquires Canadian CRO NuChem Sciences
Aug 3, 2023 8:10am
Sygnature Discovery buys Peak Proteins to bolster drug discovery
Apr 27, 2022 7:00am
Sygnature Discovery snaps up fellow British CRO XenoGesis
Sep 29, 2020 7:45am
Allergan vet Saunders nabs BridgeBio board seat—Chutes & Ladders
Jun 26, 2020 9:30am
